Large-scale testing (Phase 3)Looking for participantsNCT07571161
What this trial is testing
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
Who this might be right for
Alzheimer Disease
Eli Lilly and Company 140